AI THERAPEUTICS Trademark

Trademark Overview


On Friday, February 10, 2023, a trademark application was filed for AI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AI THERAPEUTICS trademark a serial number of 97789413. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 20, 2023. This trademark is owned by AI Therapeutics, Inc.. The AI THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases

Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
ai therapeutics

General Information


Serial Number97789413
Word MarkAI THERAPEUTICS
Filing DateFriday, February 10, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a design of a central point with three immediate extending lines. The top and left lines branch into two similar lines with rounded circular ends and the right line contains an additional line on one side and a single dot on the other side. To the right of the design are the words "AI THERAPEUTICS".
Goods and ServicesPharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAI Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437

Trademark Events


Event DateEvent Description
Tuesday, February 14, 2023NEW APPLICATION ENTERED
Wednesday, March 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 2, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 29, 2023ASSIGNED TO EXAMINER
Tuesday, September 5, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 20, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, December 20, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, March 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED